Literature DB >> 12174849

Bupropion for adults with attention deficit hyperactivity disorder.

Jeffery H Newcorn.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12174849     DOI: 10.1007/s11920-002-0039-0

Source DB:  PubMed          Journal:  Curr Psychiatry Rep        ISSN: 1523-3812            Impact factor:   5.285


× No keyword cloud information.
  5 in total

1.  Bupropion hydrochloride in attention deficit disorder with hyperactivity.

Authors:  C K Conners; C D Casat; C T Gualtieri; E Weller; M Reader; A Reiss; R A Weller; M Khayrallah; J Ascher
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1996-10       Impact factor: 8.829

2.  Pharmacotherapy of attention-deficit/hyperactivity disorder reduces risk for substance use disorder.

Authors:  J Biederman; T Wilens; E Mick; T Spencer; S V Faraone
Journal:  Pediatrics       Date:  1999-08       Impact factor: 7.124

Review 3.  Attention-deficit/hyperactivity disorder in adults: an overview.

Authors:  S V Faraone; J Biederman; T Spencer; T Wilens; L J Seidman; E Mick; A E Doyle
Journal:  Biol Psychiatry       Date:  2000-07-01       Impact factor: 13.382

4.  Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder.

Authors:  T E Wilens; J Biederman; J Prince; T J Spencer; S V Faraone; R Warburton; D Schleifer; M Harding; C Linehan; D Geller
Journal:  Am J Psychiatry       Date:  1996-09       Impact factor: 18.112

5.  A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder.

Authors:  T Spencer; T Wilens; J Biederman; S V Faraone; J S Ablon; K Lapey
Journal:  Arch Gen Psychiatry       Date:  1995-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.